(Q37309288)

19 August 2017

1 reference

title

A review of medical treatments of cerebral vasospasm (English)

1 reference

19 August 2017

1

Marc L Otten

1 reference

19 August 2017

3

E Sander Connolly

1 reference

19 August 2017

2

J Mocco

1 reference

19 August 2017

Robert A Solomon

4

1 reference

19 August 2017

publication date

1 June 2008

1 reference

19 August 2017

published in

Neurological Research

1 reference

19 August 2017

volume

30

1 reference

19 August 2017

issue

5

1 reference

19 August 2017

page(s)

444-449

1 reference

Subarachnoid haemorrhage: diagnosis, causes and management

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

A review of current and future medical therapies for cerebral vasospasm following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Surgical bleeding and calcium antagonists. British aneurysm nimodipine trial reported improved clinical outcome with nimodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Treatment of cerebral vasospasm with intra-arterial papaverine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Magnesium and experimental vasospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Rapid reversal of endothelin-1-induced cerebral vasoconstriction by intrathecal administration of nitric oxide donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Cerebrovascular inflammation following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Subarachnoid hemorrhage and inflammation: bench to bedside and back

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Nitric oxide: mediator, murderer, and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Biosynthesis and metabolism of endothelium-derived nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Molecular keys to the problems of cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

A review of hemoglobin and the pathogenesis of cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Intravenous nitroglycerin in experimental cerebral vasospasm. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Regional cerebral blood flow in apoplexy due to occlusion of the middle cerebral artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Relation of cerebral energy metabolism and extracellular nitrite and nitrate concentrations in patients after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X284089

21 January 2018

Identifiers

DOI

10.1179/174313208X284089

1 reference

19 August 2017

1 reference